undamentalytics Newsletter

Wallace Noel R.: insider trades

Chief executive, Officer at Colgate-Palmolive. No open-market purchases and 35 sales not made under a pre-set plan, reported from March 3, 2010 to August 6, 2026.

What happened after Wallace Noel R.’s sales?

After their sales, the shares moved −3.6% against the index over 12 months on average (a negative figure means selling was the right call); 55% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Wallace Noel R.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 34 −1.5% −2.3% 62% 13 −1.75 0.11 No reliable evidence
Sales, 12 months after the report 33 −3.6% −1.2% 55% 12 −1.39 0.19 No reliable evidence
Sales, 12 months after the trade 33 −4.2% −3.8% 55% 12 −1.45 0.17 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Colgate-Palmolive CL Chairman, President & CEO035March 3, 2010August 6, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 6, 2026August 4, 2026 CL Sale $29,698,713 not yetnot yetnot yet
February 6, 2026February 4, 2026 CL Sale $4,279,291 −14.1%not yetnot yet
November 8, 2021November 4, 2021 CL Sale $18,946,536 +5.9%+15.1%+15.2%
May 7, 2021May 5, 2021 CL Sale $2,048,357 −11.6%−1.2%−7.7%
November 19, 2020November 17, 2020 CL Sale $1,841,354 −20.2%−40.3%−38.7%
November 12, 2020November 9, 2020 CL Sale $2,253,047 −17.6%−38.5%−36.1%
November 9, 2020November 5, 2020 CL Sale $1,377,138 −16.2%−36.5%−39.7%
August 7, 2020August 5, 2020 CL Sale $6,562,398 +4.2%−28.9%−29.1%
May 3, 2019May 1, 2019 CL Sale $6,063,993 −0.9%−0.4%−0.6%
August 3, 2018August 1, 2018 CL Sale $2,955,068 −5.9%+4.1%+4.3%
May 16, 2018May 14, 2018 CL Sale $2,851,178 +2.9%+11.7%+11.6%
February 2, 2018January 31, 2018 CL Sale $9,318,204 −11.0%−9.3%−7.7%
November 14, 2017November 10, 2017 CL Sale $400,257 −7.9%−20.2%−21.7%
August 4, 2016August 2, 2016 CL Sale $5,889,232 −1.0%−17.6%−19.3%
May 11, 2016May 9, 2016 CL Sale $643,568 −2.8%−17.8%−16.9%
May 5, 2016May 3, 2016 CL Sale $4,329,600 −2.2%−16.7%−17.0%
November 19, 2015November 17, 2015 CL Sale $261,653 +8.1%−5.0%−3.8%
May 11, 2015May 8, 2015 CL Sale $246,096 +1.3%+8.1%+8.3%
February 19, 2015February 17, 2015 CL Sale $4,171,802 −3.0%+4.4%+4.1%
May 5, 2014May 1, 2014 CL Sale $2,259,977 −7.2%−9.7%−10.9%
May 7, 2013May 3, 2013 CL Sale $103,139 −2.4%−3.4%−6.2%
February 7, 2013February 5, 2013 CL Sale $878,880 +3.8%−5.0%−5.4%
May 3, 2012May 1, 2012 CL Sale $248,600 +5.8%+2.5%+7.9%
November 3, 2011November 1, 2011 CL Sale $2,770,780 −3.5%+8.4%+3.6%
September 14, 2011September 12, 2011 CL Sale $62,536 −3.4%−8.6%−5.8%
July 15, 2011July 14, 2011 CL Sale $29,538 +11.3%+16.0%+18.4%
May 11, 2011May 10, 2011 CL Sale $135,623 +9.9%+14.3%+17.0%
May 9, 2011May 6, 2011 CL Sale $11,336 +11.2%+17.0%+16.1%
May 6, 2011May 5, 2011 CL Sale $13,960 +14.3%+16.3%+15.1%
February 28, 2011February 28, 2011 CL Sale $19,628 +10.1%+16.4%+16.1%
February 16, 2011February 14, 2011 CL Sale $145,694 +10.9%+18.4%+16.0%
November 10, 2010November 8, 2010 CL Sale $77,450 −6.5%+13.7%+12.1%
August 6, 2010August 5, 2010 CL Sale $63,370 −6.8%+10.2%+1.3%
May 12, 2010May 11, 2010 CL Sale $171,645 −0.9%−11.0%−13.6%
March 3, 2010March 2, 2010 CL Sale $13,572 −4.4%−25.6%−23.9%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Wallace Noel R. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.